RNC Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,750
Closed -$273K 158
2019
Q3
$273K Hold
2,750
0.02% 130
2019
Q2
$254K Sell
2,750
-375
-12% -$35.6K 0.02% 129
2019
Q1
$295K Sell
3,125
-60
-2% -$5.25K 0.02% 113
2018
Q4
$204K Sell
3,185
-490
-13% -$36.2K 0.02% 129
2018
Q3
$329K Sell
3,675
-429
-10% -$37.9K 0.02% 109
2018
Q2
$326K Sell
4,104
-716
-15% -$59.5K 0.02% 107
2018
Q1
$430K Sell
4,820
-450
-9% -$43.2K 0.03% 101
2017
Q4
$550K Hold
5,270
0.04% 97
2017
Q3
$768K Hold
5,270
0.06% 81
2017
Q2
$684K Buy
5,270
+45
+0.9% +$5.51K 0.05% 85
2017
Q1
$650K Hold
5,225
0.05% 84
2016
Q4
$605K Sell
5,225
-35
-0.7% -$3.9K 0.05% 97
2016
Q3
$550K Buy
5,260
+190
+4% +$20.6K 0.05% 82
2016
Q2
$500K Buy
5,070
+160
+3% +$16.6K 0.05% 89
2016
Q1
$491K Sell
4,910
-375
-7% -$38.6K 0.05% 87
2015
Q4
$633K Sell
5,285
-400
-7% -$46.3K 0.06% 85
2015
Q3
$615K Sell
5,685
-63
-1% -$7.82K 0.06% 76
2015
Q2
$665K Sell
5,748
-89
-2% -$10.2K 0.06% 73
2015
Q1
$673K Buy
5,837
+665
+13% +$79.5K 0.06% 74
2014
Q4
$579K Buy
5,172
+548
+12% +$57.8K 0.05% 84
2014
Q3
$438K Buy
4,624
+100
+2% +$9.02K 0.04% 84
2014
Q2
$389K Sell
4,524
-1,752
-28% -$133K 0.03% 93
2014
Q1
$438K Buy
6,276
+580
+10% +$45.9K 0.04% 92
2013
Q4
$481K Buy
5,696
+276
+5% +$21.8K 0.04% 84
2013
Q3
$418K Sell
5,420
-350
-6% -$24.5K 0.04% 82
2013
Q2
$337K Buy
+5,770
New +$347K 0.04% 89

Other funds holding CELG

RNC Capital Management's CELG Position: Q4 2019 in Review

RNC Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,750 shares — an estimated $273K sold.

RNC Capital Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $768K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • RNC Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • RNC Capital Management sold 2,750 Celgene Corp shares in Q4 2019, an estimated $273K.
  • RNC Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • RNC Capital Management's Celgene Corp position peaked at $768K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on RNC Capital Management's 13F filing for Q4 2019, filed 9 Mar 2020.